IPO Supply Is Reopening—Liquidity Will Decide What Holds

The headline IPO market is reopening—but the real test is absorption

The U.S. primary market is entering the fall with a large pipeline and a market-structure backdrop that could make liquidity as important as demand. Renaissance Capital reports that U.S. IPOs had raised $146 billion year to date through September 8, including $71 billion excluding SpaceX, while its IPO Index was up 15% for the year but below its summer high. The firm expects a steady fall stream led by AI, alongside fintech, defense and consumer offerings.^[1]

That is a constructive setup, but not a blanket endorsement of every new issue. New listings, follow-on offerings, lockup releases and repurchases all change the amount of stock available to trade. When supply arrives faster than investors can absorb it, volatility and price discovery do the work. When demand is durable, issuance can deepen markets and give companies capital to expand.

Market Brief thesis: earnings growth and resilient demand can still support the specified DDOG, SNOW, RH, WSM, ETH, LZB, LESL and TPX research universe over the next year—but the evidence is uneven, and the next leg will depend on whether operating momentum survives a rising equity-supply calendar.

What is changing in the supply calendar

The IPO calendar is not the whole primary market. Investors should track four channels:

The near-term calendar already illustrates why precision matters. IPOscoop lists Holtec Nuclear Corp. under the symbol HNUC with an expected September 18, 2026 trading date and a preliminary 50 million-share range at $15 to $18; those are offering-calendar terms, not final pricing or a guarantee that the deal closes on schedule.^[2] Separately, a lockup-calendar listing shows MiniMed Group with 252.81 million shares scheduled to unlock on September 2, 2026. A scheduled unlock is a potential supply event—not proof that all unlocked holders will sell.^[2]

Market plumbing is part of the investment story

The SEC proposed registered-offering reforms in May that would broaden access to shelf offerings, expand certain offering and communication flexibilities, streamline incorporation by reference for Form S-1, and give many newly public companies a longer period of scaled disclosure accommodations. The proposal would also raise the large-accelerated-filer threshold from $700 million to $2 billion and provide an IPO on-ramp of at least 60 months. These are proposals, not final rules.^[3]

If adopted, those changes could lower friction for follow-on capital and make public markets more accessible to smaller and mid-sized issuers. The tradeoff is that easier access can also mean more frequent supply. Market quality will therefore depend on displayed depth, spreads, execution costs and the ability of investors to distinguish durable capital formation from opportunistic distribution.

Regulation NMS remains another live plumbing variable. The SEC’s 2024 final rule addressed minimum pricing increments, access fees and transparency of better-priced orders, while 2026 proposals and exemptive actions show that implementation and market-quality debates remain active.^[4] For newly listed and smaller companies, the practical question is not only whether a market exists, but how much size it can absorb without a sharp price concession.

Testing the demand hypothesis across the research universe

The strongest current operating evidence in this pass comes from DDOG. Datadog reported second-quarter 2026 revenue of $1.12 billion, up 36% year over year, with about 4,720 customers at $100,000 or more of annual recurring revenue versus about 3,850 a year earlier. It guided to full-year 2026 revenue of $4.45 billion to $4.47 billion.^[5]

That is evidence in favor of the hypothesis that resilient technology demand can support earnings growth. It is not evidence that the entire group will behave the same way: DDOG’s enterprise software and AI-exposure drivers differ materially from SNOW’s consumption model, RH and WSM’s higher-end home exposure, and LZB, LESL and TPX’s furniture and mattress demand.

The market’s reaction also matters. DDOG’s end-of-day close was $221.21 on September 10, 2026, versus $129.23 on March 17, while SNOW’s close was $328.99 versus $174.60 over the same quoted window. These are closing-price observations, not total returns, and they do not establish causality; they do show that the growth cohort has already experienced substantial repricing and may be sensitive to any evidence that demand, usage or margins are decelerating.^[6][7]

For the other names in scope, this pass does not establish a comparable, source-backed current earnings datapoint. That is a limitation, not a negative conclusion. The proper test is to update the evidence as each company reports rather than fill the gap with sector assumptions.

Earnings checkpoints and what they can reveal

The current calendar lists the following upcoming dates as estimated, with session labels shown exactly as supplied by the calendar: DDOG on November 5 before the open; SNOW on December 2 after the close; RH on December 10 after the close; WSM on November 18 before the open; LZB on November 17 after the close; and LESL on December 1 after the close. ETH and TPX have no confirmed date in the calendar.^[8]

Those reports can help separate the two sides of the hypothesis:

• Demand confirmation: revenue growth, bookings or ARR, comparable sales, unit volumes, repeat purchases and customer additions.
• Quality of growth: gross margin, operating leverage, free cash flow and inventory discipline.
• Supply pressure: equity compensation, convertible dilution, insider selling, secondary offerings and post-lockup trading.
• Market acceptance: price reaction relative to the reported result, trading volume, spreads and whether a beat produces follow-through rather than a one-day spike.

DDOG’s Q2 release is a useful reminder to keep GAAP and adjusted measures separate: the company reported GAAP operating income of $5 million and non-GAAP operating income of $257 million.^[5] Strong adjusted profitability can coexist with meaningful stock-based compensation and dilution considerations, so liquidity analysis should include share-count trends rather than focusing only on revenue growth.

What would falsify the thesis?

The constructive case weakens if several signals appear together:

1. Revenue or usage decelerates across the software names while sales and marketing costs remain elevated.
2. RH, WSM, LZB, LESL or TPX show persistent demand pressure, discounting or inventory accumulation rather than a cyclical stabilization.
3. New issues price successfully but trade below offer levels as follow-ons and lockups add supply.
4. Buyback authorizations do not translate into completed repurchases, leaving issuance and dilution unoffset.
5. Wider spreads, thinner displayed depth or higher volatility make secondary capital materially more expensive.

The opposite combination—durable demand, improving margins, orderly lockup absorption and healthy post-IPO liquidity—would strengthen the case. Neither outcome is guaranteed by a strong IPO headline.

What to watch next

• Final pricing, allocation and first-day trading for the fall IPO pipeline, including whether preliminary terms change before pricing.
• Secondary-offering announcements and whether proceeds fund growth, refinance obligations or primarily provide liquidity to existing holders.
• The size and actual trading behavior around upcoming lockup releases; distinguish shares becoming eligible to sell from shares actually sold.
• Completed buyback activity and diluted share counts, not merely authorization headlines.
• DDOG, SNOW, RH, WSM, LZB and LESL earnings against the estimated calendar dates above; TPX and ETH remain without a confirmed date in the current calendar.^[8]
• SEC action on registered-offering reform and related market-quality rules; proposals can change before adoption.^[3]

The balanced conclusion is that resilient demand can support the research universe, but the next year will be decided by the interaction of earnings with supply. A reopened IPO market is healthy when capital formation is absorbed by durable demand; it becomes a volatility source when issuance, lockups and dilution outrun liquidity.